SARS-CoV-2 one year on: evidence for ongoing viral adaptation.

SARS-CoV-2 one year on: evidence for ongoing viral adaptation.
复制标题

DOI:
10.1099/jgv.0.001584
复制
发表时间:
2021-04
期刊:
The Journal of general virology
影响因子:
--
通讯作者:
Barclay WS
Barclay WS
中科院分区:
其他
文献类型:
--
作者:
Peacock TP;Penrice-Randal R;Hiscox JA;Barclay WS

文献摘要

参考文献

被引文献

相似文献

SARS-CoV-2被认为起源于人畜共患病的溢出事件。人类感染导致多种后果,从无症状病例到COVID-19疾病,其可能具有显著的发病率和死亡率,截至2021年1月,全球有超过200万例确诊死亡。大流行一年多来,测序分析表明,随着SARS-CoV-2病毒继续在人群中广泛传播,该病毒的变种正在被选择。SARS-CoV-2内遗传变异的主要驱动因素是由聚合酶错误引起的单核苷酸多态性(SNP)、潜在的宿主因子驱动的RNA修饰以及由病毒RNA合成的不连续性质引起的插入/缺失(indels)。虽然许多突变代表中性的“遗传漂变”或已迅速消失,但一个子集可能影响病毒特性,如病毒的传播性、致病性、宿主范围和抗原性。在这篇综述中,我们总结了目前SARS-CoV-2的遗传变化程度,特别是最近出现的令人担忧的变异,并考虑了这种病毒进化的表型后果,可能会影响未来的大流行的轨迹。
SARS-CoV-2 is thought to have originated in the human population from a zoonotic spillover event. Infection in humans results in a variety of outcomes ranging from asymptomatic cases to the disease COVID-19, which can have significant morbidity and mortality, with over two million confirmed deaths worldwide as of January 2021. Over a year into the pandemic, sequencing analysis has shown that variants of SARS-CoV-2 are being selected as the virus continues to circulate widely within the human population. The predominant drivers of genetic variation within SARS-CoV-2 are single nucleotide polymorphisms (SNPs) caused by polymerase error, potential host factor driven RNA modification, and insertion/deletions (indels) resulting from the discontinuous nature of viral RNA synthesis. While many mutations represent neutral ‘genetic drift’ or have quickly died out, a subset may be affecting viral traits such as transmissibility, pathogenicity, host range, and antigenicity of the virus. In this review, we summarise the current extent of genetic change in SARS-CoV-2, particularly recently emerging variants of concern, and consider the phenotypic consequences of this viral evolution that may impact the future trajectory of the pandemic.
DOI: 10.1038/s41598-019-40564-z
发表时间: 2019-03-08
期刊: SCIENTIFIC REPORTS
影响因子: 4.6
作者:
Chen, Fangzhou;Knutson, Todd P.;Marthaler, Douglas G.
通讯作者: Marthaler, Douglas G.
整合素结合肽 ATN-161,作为 SARS-CoV-2 感染的新疗法。
DOI: 10.1016/j.jacbts.2020.10.003
发表时间: 2021-01
期刊: JACC. Basic to translational science
影响因子: --
作者:
Beddingfield BJ;Iwanaga N;Chapagain PP;Zheng W;Roy CJ;Hu TY;Kolls JK;Bix GJ
通讯作者: Bix GJ
DOI: 10.1038/s41586-021-03739-1
发表时间: 2021-08
期刊: Nature
影响因子: 64.8
作者:
Collier DA;Ferreira IATM;Kotagiri P;Datir RP;Lim EY;Touizer E;Meng B;Abdullahi A;CITIID-NIHR BioResource COVID-19 Collaboration;Elmer A;Kingston N;Graves B;Le Gresley E;Caputo D;Bergamaschi L;Smith KGC;Bradley JR;Ceron-Gutierrez L;Cortes-Acevedo P;Barcenas-Morales G;Linterman MA;McCoy LE;Davis C;Thomson E;Lyons PA;McKinney E;Doffinger R;Wills M;Gupta RK
通讯作者: Gupta RK
DOI: 10.1371/journal.pbio.3001016
发表时间: 2020-12
期刊: PLoS biology
影响因子: 9.8
作者:
Conceicao C;Thakur N;Human S;Kelly JT;Logan L;Bialy D;Bhat S;Stevenson-Leggett P;Zagrajek AK;Hollinghurst P;Varga M;Tsirigoti C;Tully M;Chiu C;Moffat K;Silesian AP;Hammond JA;Maier HJ;Bickerton E;Shelton H;Dietrich I;Graham SC;Bailey D
通讯作者: Bailey D
DOI: 10.1080/22221751.2020.1806735
发表时间: 2020-12
影响因子: 13.2
作者:
Andrés C;Garcia-Cehic D;Gregori J;Piñana M;Rodriguez-Frias F;Guerrero-Murillo M;Esperalba J;Rando A;Goterris L;Codina MG;Quer S;Martín MC;Campins M;Ferrer R;Almirante B;Esteban JI;Pumarola T;Antón A;Quer J
通讯作者: Quer J